摘要 |
The present invention is related to new diselenobis benzoic acid amides of primary heterocyclic amines of the general formula I <CHEM> wherein R<1> and R<2>, which are equal or different from another, represent hydrogen, halogen, C1-4-alkyl, C1-4-alkoxy, trifluoromethyl, nitro or, both together, methylenedioxy, n is zero or a numeral from 1 to 4 and R<3> is a saturated or unsaturated heterocyclic residue with one or two heteroatoms in the cyclic nucleus selected from the group of nitrogen, sulphur and oxygen, said residues being unsubstituted or substituted onces or twice, equally or in different manner, by halogen, C1-2-alkyl, C1-2-alkoxy, nitro or hydroxy. processes for producing the same and pharmaceutical compositions comprising the same. The compounds of formula I are useful in the treatment of diseases which are caused by cell damage due to the increased formation of active oxygen metabolites such as liver damages, heart infarctions, infections, psoriasis or damages by radiation. |